Migraine Patients Have a Say in ICER Review of CGRP Treatments

ICER is currently reviewing the new class of CGRP inhibitor medications for migraine prevention. At least one of these new treatments is expected to be available by prescription in 2018. Part of the ICER Review of CGRP inhibitor medications includes requests for patient input.
ICER Review

Leave a Reply

Your email address will not be published. Required fields are marked *